Dr. Erkan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
535 East 70th Street
6th Floor
New York, NY 10021Phone+1 212-774-2291Fax+1 212-774-2374- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1995 - 1998
Hacettepe University FOMClass of 1995
Certifications & Licensure
NY State Medical License 2001 - 2025
FL State Medical License 2012 - 2014- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome Start of enrollment: 2007 Sep 01
- Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients Start of enrollment: 2008 May 01
- Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry".Isaac Pons, Alba Jeréz, Gerard Espinosa, Ignasi Rodríguez-Pintó, Yehuda Shoenfeld, Ricard Cervera, , Doruk Erkan> ;Seminars in Arthritis and Rheumatism. 2024 Mar 26
- 2 citationsDamage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.Balbi, G., Ahmadzadeh, Y., Tektonidou, M., Pengo, V., Sciascia, S., Ugarte, A., Belmont, H., Lopez-Pedrera, C., Fortin, P., Wahl, D., Gerosa, M., de Jesús, G., Ji, L.,...> ;Rheumatology. 2024 Mar 1
- Persistent Moderate-to-High Level Isolated Anticardiolipin Antibody IgA or Anti-B2-Glycoprotein-I IgA Isotypes: Do They Have Any Clinical Relevance?Keleşoğlu Dinçer, A., Thaler, J., Erkan, D.> ;Turkish Journal of Haematology. 2024 Feb 27
- Join now to see all
Journal Articles
- Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology
Lectures
- New Diagnostic and Treatment Strategies for Antiphospholipid Syndrome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Other
- McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid SyndromeDoruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-08-13 - McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid SyndromeDoruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-07-26
Press Mentions
Novel Anti-NET Antibodies in a Multinational CohortMarch 28th, 2023- Updates on the ACR/EULAR Antiphospholipid SyndromeDecember 12th, 2022
- Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid SyndromeAugust 3rd, 2020
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Hospital for Special SurgeryNew York, New York
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
